Trastuzumab Completed Phase 0 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT00949247Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases